Jump Financial, LLC Royalty Pharma PLC Transaction History

Jump Financial, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	SELL	$26.21 - $29.22 $5.02 Million - $5.6 Million	-191,700 Reduced 94.43%	11,300 $317,000
Q4 2023 Feb 07, 2024	SELL	$26.21 - $29.22 $5.02 Million - $5.6 Million	-191,700 Reduced 94.43%	11,300 $317,000
Q3 2023 Oct 21, 2024	SELL	$26.26 - $31.38 $6.65 Million - $7.95 Million	-253,285 Reduced 55.51%	203,000 $5.51 Million
Q3 2023 Nov 07, 2023	SELL	$26.26 - $31.38 $6.65 Million - $7.95 Million	-253,285 Reduced 55.51%	203,000 $5.51 Million
Q2 2023 Oct 21, 2024	BUY	$29.6 - $36.56 $13.5 Million - $16.7 Million	456,285 New	456,285 $14 Million
Q2 2023 Aug 07, 2023	BUY	$29.6 - $36.56 $13.5 Million - $16.7 Million	456,285 New	456,285 $14 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $56,248 - $63,241	1,436 Added 19.9%	8,651 $341,000
Q3 2022 Nov 07, 2022	BUY	$39.88 - $44.65 $287,734 - $322,149	7,215 New	7,215 $290,000
Q1 2022 May 12, 2022	SELL	$37.46 - $42.44 $367,332 - $416,166	-9,806 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$35.17 - $42.48 $344,877 - $416,558	9,806 New	9,806 $391,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.